Wells Fargo & Company Oramed Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

  • $507 Billion
  • Q3 2025

A detailed history of Wells Fargo & Company transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 130,086 shares of ORMP stock, worth $309,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,086
Previous 20,986 519.87%
Holding current value
$309,604
Previous $47,000 612.77%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$2.06 - $2.7 $224,746 - $294,570
109,100 Added 519.87%
130,086 $335,000
Q1 2025

May 13, 2025
SELL
$2.0 - $2.62 $5,200 - $6,812
-2,600 Reduced 11.02%
20,986 $44,000
Q4 2024

Feb 12, 2025
SELL
$2.17 - $2.52 $3,255 - $3,780
-1,500 Reduced 5.98%
23,586 $57,000
Q3 2024

Nov 13, 2024
SELL
$2.21 - $2.63 $1,105 - $1,315
-500 Reduced 1.95%
25,086 $61,000
Q2 2024

Aug 13, 2024
BUY
$2.07 - $2.83 $37,435 - $51,180
18,085 Added 241.1%
25,586 $65,000
Q1 2024

May 10, 2024
BUY
$2.18 - $3.58 $6,540 - $10,740
3,000 Added 66.65%
7,501 $21,000
Q3 2023

Nov 13, 2023
SELL
$2.51 - $3.55 $3,764 - $5,325
-1,500 Reduced 25.0%
4,501 $11,000
Q2 2023

Aug 15, 2023
BUY
$2.12 - $4.47 $4,030 - $8,497
1,901 Added 46.37%
6,001 $21,000
Q1 2023

May 12, 2023
SELL
$1.93 - $13.1 $116,923 - $793,624
-60,582 Reduced 93.66%
4,100 $8,000
Q4 2022

Feb 13, 2023
BUY
$5.88 - $12.03 $31,458 - $64,360
5,350 Added 9.02%
64,682 $778,000
Q3 2022

Nov 14, 2022
BUY
$4.6 - $9.91 $247,277 - $532,721
53,756 Added 964.06%
59,332 $384,000
Q2 2022

Aug 12, 2022
SELL
$3.72 - $9.0 $459,364 - $1.11 Million
-123,485 Reduced 95.68%
5,576 $26,000
Q1 2022

May 16, 2022
BUY
$8.19 - $13.89 $312,030 - $529,195
38,099 Added 41.88%
129,061 $1.12 Million
Q4 2021

Feb 14, 2022
BUY
$12.98 - $29.75 $1.07 Million - $2.45 Million
82,213 Added 939.68%
90,962 $1.3 Million
Q3 2021

Nov 15, 2021
BUY
$12.13 - $23.82 $42,236 - $82,941
3,482 Added 66.11%
8,749 $192,000
Q2 2021

Aug 16, 2021
BUY
$8.34 - $14.59 $15,987 - $27,969
1,917 Added 57.22%
5,267 $71,000
Q1 2021

May 13, 2021
BUY
$4.22 - $11.33 $2,110 - $5,665
500 Added 17.54%
3,350 $34,000
Q3 2020

Nov 05, 2020
SELL
$2.58 - $4.16 $4,063 - $6,552
-1,575 Reduced 35.59%
2,850 $7,000
Q2 2020

Aug 13, 2020
BUY
$2.87 - $4.12 $1,650 - $2,369
575 Added 14.94%
4,425 $16,000
Q1 2020

May 14, 2020
BUY
$2.6 - $5.5 $10,010 - $21,175
3,850 New
3,850 $12,000

Others Institutions Holding ORMP

# of Institutions
53
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $92.4M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email